[Diabetes as a complication in treatment with second-generation antipsychotics].
Povlsen
Uffe Juul
UJ
H:S Rigshospitalet, Psykiatrisk Klinik, København. juul.povlsen@rh.dk
Breum
Leif
L
Lublin
Henrik K F
HK
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects; D003024:Clozapine / Q000009:adverse effects; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D000077152:Olanzapine; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy; D012702:Serotonin Antagonists / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D003024:Clozapine; D000077152:Olanzapine; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors
Diabetes som komplikation til behandling med 2.-generations-antipsykotika.